Engaging in Short-Term Moderate-Intensity Exercise Increases Growth Hormone Levels in Individuals with Obesity DOI Creative Commons

Muhammad Muhammad,

Gigih Siantoro, Irmantara Subagio

et al.

Physical Education Theory and Methodology, Journal Year: 2024, Volume and Issue: 24(4), P. 619 - 625

Published: Aug. 26, 2024

Objectives. This study aimed to analyze the effect of a four-week moderate-intensity exercise regimen on increasing growth hormone (GH) levels in individuals with obesity. Materials and methods. A total 25 female aged 20-25 years, body mass index (BMI) 27.50-37.00 kg/m², were involved randomly divided into two groups, namely control group (CON; n = 12) (MIE; 13). The (treadmill for 30 minutes at 60-70% HRmax, resistance 1RM) was conducted 3 times per week period 4 weeks. Blood samples from participants collected pre- post-exercise sessions, GH analyzed using Enzyme-Linked Immunosorbent Assay method. Data analysis techniques used paired sample t-test significance level 5 %. Results. results between pre-exercise sessions CON showed change (1291.79 ± 383.76 1151.53 484.80 pg/mL; p 0.694), while MIE demonstrated following dynamics — (1161.79 133.72 2103.83 357.09 0.006). Conclusions. main findings this revealed that after implementing intervention, significant increase observed obese females.

Language: Английский

Metabolically healthy obesity: from epidemiology and mechanisms to clinical implications DOI
Matthias B. Schulze, Norbert Stefan

Nature Reviews Endocrinology, Journal Year: 2024, Volume and Issue: 20(11), P. 633 - 646

Published: June 27, 2024

Language: Английский

Citations

31

Metabolic dysfunction-associated steatotic liver disease: heterogeneous pathomechanisms and effectiveness of metabolism-based treatment DOI Creative Commons
Norbert Stefan, Hannele Yki‐Järvinen, Brent A. Neuschwander‐Tetri

et al.

The Lancet Diabetes & Endocrinology, Journal Year: 2024, Volume and Issue: unknown

Published: Dec. 1, 2024

Language: Английский

Citations

19

Flavonoids for gastrointestinal tract local and associated systemic effects: A review of clinical trials and future perspectives DOI Creative Commons
Xiaopeng Li, Enjun Xie,

Shumin Sun

et al.

Journal of Advanced Research, Journal Year: 2025, Volume and Issue: unknown

Published: Jan. 1, 2025

Flavonoids are naturally occurring dietary phytochemicals with significant antioxidant effects aside from several health benefits. People often consume them in combination other food components. Compiling data establishes a link between bioactive flavonoids and prevention of diseases animal models, including cardiovascular diseases, diabetes, gut dysbiosis, metabolic dysfunction-associated steatotic liver disease (MASLD). However, numerous clinical studies have demonstrated the ineffectiveness contradicting rodent thereby challenging validity using as supplements. This review provides perspective to emphasize effective roles well summarize their specific mechanisms animals briefly. First, this offers an in-depth elucidation processes within human, encompassing small, large intestine, liver. Furthermore, comprehensive overview various functions gastrointestinal tract, hindering breakdown assimilation macronutrients, such polysaccharides lipids, regulating hormone secretion inhibition mineral iron absorption. In unabsorbed major portion interact flora leading biotransformation. Once absorbed circulated bloodstream, or metabolites exert beneficial systemic effects. Lastly, we examine protective disorders, endothelial dysfunction, MASLD, disease, obesity, hyperlipidemia, insulin resistance. conclusion, outlines safety future prospects field health, especially syndrome (MetS).

Language: Английский

Citations

3

Integrative Metabolism in MASLD and MASH: Pathophysiology and Emerging Mechanisms DOI Creative Commons
Gregory R. Steinberg, Celina M Valvano, William De Nardo

et al.

Journal of Hepatology, Journal Year: 2025, Volume and Issue: unknown

Published: March 1, 2025

The liver acts as a central metabolic hub, integrating signals from the gastrointestinal tract and adipose tissue to regulate carbohydrate, lipid, amino acid metabolism. Gut-derived metabolites, such acetate ethanol non-esterified fatty acids white (WAT), influence hepatic processes, which rely on mitochondrial function maintain systemic energy balance. Metabolic dysregulation obesity, insulin resistance, type 2 diabetes disrupt these pathways, leading dysfunction-associated steatotic disease (MASLD) steatohepatitis (MASH). This review explores fluxes within gut-adipose tissue-liver axis, focusing pivotal role of de novo lipogenesis (DNL), dietary substrates like glucose fructose, changes in during MASLD progression. It highlights contributions resistance impaired dynamics lipid accumulation. Further understanding how interplay between substrate flux gastro-intestinal integrates with intersects structural functional alterations mitochondria will be important identify novel therapeutic targets advance treatment MASH.

Language: Английский

Citations

2

Prediabetes remission to reduce the global burden of type 2 diabetes DOI Creative Commons

Leontine Sandforth,

Stephanie Kullmann, Arvid Sandforth

et al.

Trends in Endocrinology and Metabolism, Journal Year: 2025, Volume and Issue: unknown

Published: Feb. 1, 2025

Prediabetes is a highly prevalent and increasingly common condition affecting significant proportion of the global population. The heterogeneous nature prediabetes presents challenge in identifying individuals who particularly benefit from lifestyle or other therapeutic interventions aiming at preventing type 2 diabetes (T2D) associated comorbidities. phenotypic characteristics risk for are with both specific profiles progression differential potential to facilitate remission reduce future T2D. This review examines current definition prevalence evaluates alarming increase burden

Language: Английский

Citations

1

Comment on Rhee et al. Discrepancy Between Genetically Predicted and Observed BMI Predicts Incident Type 2 Diabetes. Diabetes Care 2024;47:1826–1833 DOI Open Access

Benlin Huang,

Kun Zhao

Diabetes Care, Journal Year: 2025, Volume and Issue: 48(3), P. e36 - e36

Published: Feb. 20, 2025

Language: Английский

Citations

1

Cardioprotective benefits of metabolic surgery and GLP-1 receptor agonist–based therapies DOI

Arianne Morissette,

Erin E. Mulvihill

Trends in Endocrinology and Metabolism, Journal Year: 2024, Volume and Issue: unknown

Published: Aug. 1, 2024

Language: Английский

Citations

5

Navigating obesity: A comprehensive review of epidemiology, pathophysiology, complications and management strategies DOI

Ning Xiao,

Yi Ding, Bing Cui

et al.

The Innovation Medicine, Journal Year: 2024, Volume and Issue: 2(3), P. 100090 - 100090

Published: Jan. 1, 2024

<p>Obesity, a growing global health crisis, is driven by complex interplay of genetic, biological, environmental, behavioral, socio-cultural, and economic factors. This comprehensive review encapsulates the epidemiology, pathophysiological mechanism, myriad complications it triggers, such as cardiovascular diseases (CVDs), cancer, neurological disorders, respiratory ailments, digestive diseases, mobility impairments, psychological stress. The etiology obesity multifaceted, involving genetic predispositions, environmental influences, behavioral tendencies, socio-economic elements. underpinnings encompass multifaceted aspects energy metabolism, including regulation appetite, glucose, lipid, amino acid metabolism. also addresses seemingly contradictory roles in various offering insights into these phenomena. management multi-pronged, lifestyle modifications, pharmacological interventions, metabolic surgeries. Lifestyle changes are foundational, but advancements molecular techniques, digital technology, wearable devices, artificial intelligence opening new avenues for personalized treatment early intervention. Pharmacological surgery effective should be judiciously tailored to individual patient needs. underscores importance approach management, aiming curb escalating trend enhance future interventions treatments. ultimate goal synthesize current evidence innovative strategies combat effectively.</p>

Language: Английский

Citations

5

Unveiling adipose populations linked to metabolic health in obesity DOI Creative Commons
Isabel Reinisch, Adhideb Ghosh, Falko Noé

et al.

Cell Metabolism, Journal Year: 2024, Volume and Issue: unknown

Published: Dec. 1, 2024

Precision medicine is still not considered as a standard of care in obesity treatment, despite large heterogeneity the metabolic phenotype individuals with obesity. One strongest factors influencing variability disease risk adipose tissue (AT) dysfunction; however, there little understanding link between distinct cell populations, cell-type-specific transcriptional programs, and severity. Here, we generated comprehensive cellular map subcutaneous visceral AT metabolically healthy unhealthy By combining single-nucleus RNA-sequencing data bulk transcriptomics clinical parameters, identified that mesothelial cells, adipocytes, adipocyte-progenitor cells exhibit correlation disease. Furthermore, uncovered cell-specific such transitioning to mesenchymal phenotype, are involved uncoupling from Together, these findings provide valuable insights by revealing biological drivers endpoints.

Language: Английский

Citations

5

Adipocyte-derived ferroptotic signaling mitigates obesity DOI Creative Commons
Xue Wang, Qian Wu, Minling Zhong

et al.

Cell Metabolism, Journal Year: 2024, Volume and Issue: unknown

Published: Dec. 1, 2024

Ferroptosis is characterized as an iron-dependent and lipophilic form of cell death. However, it remains unclear what role ferroptosis has in adipose tissue function activity. Here, we find a lower ferroptotic signature the individuals mice with obesity. We further that activation signaling by non-lethal dose agonists significantly reduces lipid accumulation primary adipocytes high-fat diet (HFD)-fed mice. Notably, adipocyte-specific overexpression acyl-coenzyme A synthetase long-chain family member 4 (Acsl4) or deletion ferritin heavy chain (Fth) protects from HFD-induced expansion metabolic disorders via signaling. Mechanistically, 5,15-dihydroxyeicosatetraenoic acid (5,15-DiHETE) activates signaling, resulting degradation hypoxia-inducible factor-1α (HIF1α), thereby derepressing thermogenic program regulated c-Myc-peroxisome proliferator-activated receptor gamma coactivator-1 beta (Pgc1β) pathway. Our findings suggest activating tissues might help to prevent treat obesity its related disorders.

Language: Английский

Citations

4